Company Description
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power.
RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.
RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
| Country | United States |
| Founded | 1997 |
| IPO Date | Jul 30, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 374 |
| CEO | Dr. Ronald M. Kurtz M.D. |
Contact Details
Address: 100 Columbia Street, Suite 120 Aliso Viejo, California 92656 United States | |
| Phone | 949-521-7822 |
| Website | rxsight.com |
Stock Details
| Ticker Symbol | RXST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $16.00 |
| CIK Code | 0001111485 |
| CUSIP Number | 78349D107 |
| ISIN Number | US78349D1072 |
| Employer ID | 94-3268801 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ronald M. Kurtz M.D. | President, Chief Executive Officer and Director |
| Shelley B. Thunen | Chief Financial Officer |
| Dr. Ilya Goldshleger Ph.D. | Chief Operating Officer |
| Eric J. Weinberg | Chief Commercial Officer |
| Rebecca Williston | Vice President of Accounting and Finance |
| Matt Haller Ph.D. | Chief Technology Officer |
| Alex Huang | Investor Relations |
| Roy Freeman | Vice President of Marketing |
| Caroline Vaughn | Vice President of Human Resources |
| Scott Gaines | Senior Vice President of Commercial Operations and Business Process |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2024 | ARS | Filing |
| Apr 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 23, 2024 | 8-K | Current Report |
| Apr 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2024 | 10-K | Annual Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 16, 2024 | 144 | Filing |